MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer

Eralp Y. , Derin D., Ozluk Y., Yavuz E., Guney N., Saip P., ...More

ANNALS OF ONCOLOGY, vol.19, no.4, pp.669-674, 2008 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 4
  • Publication Date: 2008
  • Doi Number: 10.1093/annonc/mdm522
  • Title of Journal : ANNALS OF ONCOLOGY
  • Page Numbers: pp.669-674


Background: Triple-negative breast cancer is estimated to account for 15%-20% of all patients with breast cancer and is considered as a prognostically unfavorable subset. The aim of this study is to evaluate the prognostic impact of various molecular factors in patients with triple-negative breast cancer.